News
EY Biotech Beyond Borders 2026 flags resilient biotech growth, tighter funding and Asia’s rising role
EY also pointed to regulatory shifts and “repatriating” trends, with industry leaders pledging up to US$370 billion toward domestic manufacturing in response to tariffs and supply-chain concerns. Overall, the report portrayed a sector that remained fundamentally strong, but one that needed to stay agile as capital, regulation and innovation all moved in new directions.
Wockhardt Receives U.S. FDA Approval for ZAYNICH a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
More than 2.8 million antimicrobial-resistant infections occur each year in the U.S., resulting in more than 35,000 deaths.
Biggest India Pavilion @ BIO 2026 draws global attention
The Consul General released the India Biotech Handbook 2026, brought out by ABLE to showcase the strengths of India’s BioEconomy industry.
voice for BT and BEST 2026
